in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Albemarle Expands API Production Site
12:08 AM MDT | June 27, 2012 | Deepti Ramesh
Albemarle says it has expanded and upgraded its U.S. FDA-approved multi-product active pharmaceutical ingredient (API) manufacturing facility at South Haven, MI. Production using the new expanded capacity commenced on June 1, 2012. The expansion is the latest in a series of projects at the South Haven site to increase capabilities and production throughput, meeting the increasing demand for both generic API products and custom manufacturing service portfolios, Albemarle says. In the past two years, the number of custom API projects has more than doubled at...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee